Health Dictionary Find a Doctor

Eczema

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Lixia Ellis, M.D., Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Synonyms and keywords: Atopic dermatitis; Besnier prurigo; Neurodermatitis, atopic; Eczema, atopic

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Overview

Eczema, also known as atopic dermatitis, or [atopic eczema]], is a dermatologic problem which is commonly seen in children. It is a relapsing-remitting skin problem that is predominantly manifested as pruritus, with accompanied swelling, redness, and dryness of the skin. Flaking, cracking, oozing, blistering or bleeding may occur as a result of excessive scratching of the skin.

Historical Perspective

It was in the 20th century when eczema came into existence, and later on, concepts on this had evolved including major insights on the nature of the disease.

Classification

Eczema is classified according to location, appearance, or etiology.

Pathophysiology

The mechanism of disease of eczema involves a complex interplay of abnormalities of skin microbiomes, a dysfunction in the epidermal barrier, and an immune dysregulation. There are two main theories on the existence of atopic dermatitis, also known as atopic eczema – the inside-out hypothesis, and the outside-in hypothesis.

Causes

The etiology of eczema is multifactorial and complex. This involves aberrations in genetic component, adverse effect of certain medication and some environmental factors.

Differentiating Eczema from other Diseases

Eczema has various mimics with regards to the clinical presentation, severity, and course of disease. A strong clinical evaluation by the physician based on the presenting signs and symptoms is needed to come up with the correct diagnosis. Differential diagnoses of eczema include infectious disease, inflammatory disease, immunodeficiency problem, or a nutritional deficiency.

Epidemiology and Demographics

In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. Eczema has more predilection in males.

Risk Factors

Risk factors of eczema include family history and FLG gene mutation.

Screening

Hanifin and Rajka criteria are the gold standard for diagnosing eczema.

Natural History, Complications, and Prognosis

Eczema has regarded as a medical condition with a natural history that occurs consistently. It is characterized as a disease with an early onset, mostly during the childhood period, and remits during the adolescence period. If left untreated, eczema can lead to viral, bacterial and fungal infections. Psychological problems could also arise brought about by constant itching.

Diagnosis

History and Symptoms

Family history, dietary habits, lifestyle habits, and allergies should be elicited whenever considering eczema as the primary diagnosis. This is important because eczema can be based on the patient‘s history and evolution and distribution of the skin lesion.

Physical Examination

Eczema is a [dermatologic disease]] and pruritus is the hallmark feature of this disease.

Laboratory Findings

Levels of IgE are associated with allergy, aside from parasitic infections, autoimmune diseases, and certain carcinomas.

Other Diagnostic Studies

No particular biomarker is reliable to diagnose eczema. However, the current practice is by using the laboratory levels of IgE, which when elevated, can also be associated with allergy, aside from parasitic infections, autoimmune diseases, and certain carcinomas.

Treatment

Medical Therapy

Topical corticosteroids are the mainline treatment for eczema. Different potencies of steroids are rendered specifically for the severity of eczema. Other drug treatments oftenly used for eczema include topical calcineurin inhibitors,crisaborole, antimicrobials, and antifungals.

Surgery

Surgical treatment is not commonly used as a means of management for eczema.

Primary Prevention

Primary prevention is the most effective means to avoid complications of eczema. Emolients and consumption of prebiotics and probiotics can prevent the occurrence of this condition.

Secondary Prevention

Prevention of further trans-epidermal water loss is the cornerstone of management of eczema. Since dysfunctional skin barriers could lead to water loss, daily replenishment of skin moisture is needed. This can be achieved through different modalities such as emollients, occlusives, and humectants.

Cost-Effectiveness of Therapy

The economic impact of eczema causes a burden to patients suffering from this disease. A recent study showed that an average of $274 ($199 indirect cost, and $75 direct cost) is spent by each patient for eczema.

Social Impact

Pruritus and constant scratching of the skin can significantly affect the social life of patient. Sleep disturbances, attention-deficit/hyperactivity disorder, headaches, daytime fatigue, and stunted growth are commonly seen in these patients and could lead to embarrassment and poor self-esteem.

Future or Investigational Therapies

Future trends will focus more on genetic studies in eczema.

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Overview

It was in the 20th century when eczema came into existence, and later on, concepts on this had evolved including major insights on the nature of the disease.[1]

Historical Perspectives

  • It was in the 20th century when eczema came into existence, and later on, concepts on this had evolved including major insights on the nature of the disease.[1]
  • Listed below is a summary of the history of eczema.


Table 1. History of Eczema Through the Ages.[1]
Period Highlights Treatment
Ancient History

Ebers Papyrus (1500 BCE)

Hippocrates (400 BCE)

Celsus (AD)

 " certain degree of hardness of the skin with pustules, some humid and some dry  "

Suetonius (AD)

  • The atopic syndrome found in Emperor Augustus was described in The Twelve Caesars

Avicenna (980-1037 CE)

Premodern Era

Girolamo Mercurialis (1572)

Daniel Turner
Jean-Louis Alibert (1806)
Willan and Bateman (early 19th century)
  • They are English physicians who devised a dermatological classification according to the type of primary lesion.
  • They coined the name “eczema” derived from the Greek word ‘ekzein which means to erupt or to boil over.
  • Restoration of equilibrium.
Pierre Rayer (1835)
Ferdinand von Hebra (1860)
Erasmus Wilson
  • He was credited with the discovery of infantile eczema, which was similar to the concept by Wilan and Bateman.
  • The lesion was said to be pruritic at night time.
Ernest Besnier (1892)
Twentieth Century and Beyond Von Pirquet (1906)
  • He described the concept of allergy, which meant an abnormal reaction of the body to any substance.
Coca and Cooke (1923)
  • They proposed the concept of atopy.
Wise and Sulzberger (1933)
  • They used the concept by Coca and Cooke,and was able to conceptualize the atopic dermatitis.
Blackfan and Talbot (1916)
Hanifin and Rajka (1980)

References

  1. 1.0 1.1 1.2 Bhattacharya T, Strom MA, Lio PA (2016). “Historical Perspectives on Atopic Dermatitis: Eczema Through the Ages”. Pediatr Dermatol. 33 (4): 375–9. doi:10.1111/pde.12853. PMID 27086570.
  2. Ali FR, Finlayson AE (2013). “Pharaonic trichology: the Ebers Papyrus”. JAMA Dermatol. 149 (8): 920. doi:10.1001/jamadermatol.2013.4240. PMID 24026454.
  3. Tan EK, Millington GW, Levell NJ (2009). “Acupuncture in dermatology: an historical perspective”. Int J Dermatol. 48 (6): 648–52. doi:10.1111/j.1365-4632.2009.03899.x. PMID 19538380.
  4. Liddell K (2000). “Choosing a dermatological hero for the millennium. Hippocrates of Cos (460-377 BC)”. Clin Exp Dermatol. 25 (1): 86–8. doi:10.1046/j.1365-2230.2000.0580d.x. PMID 10671984.
  5. Hajar R (2013). “The air of history (part v) ibn sina (avicenna): the great physician and philosopher”. Heart Views. 14 (4): 196–201. doi:10.4103/1995-705X.126893. PMC 3970379. PMID 24696763.
  6. Khalili M, Wong RJ (2018). “Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net”. Dig Dis Sci. 63 (12): 3250–3252. doi:10.1007/s10620-018-5316-9. PMC 6436636. PMID 30311153.
Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Overview

Eczema is classified according to location, appearance, or etiology. We have more common causes of eczema, such as seborrheic dermatitis, and less common causes such as dyshidrosis.

Eczema Classification

  • National Eczema Association classified eczema into different types.
  • Table 1 enumerates the common types of eczema with their corresponding description.[1]


Table 1. More Common types of Eczema.
Classification Description
Atopic eczema
Contact dermatitis
Seborrhoeic dermatitis

Lesser Common Types of Eczema

  • Table 2 highlights the lesser common types of eczema with their respective features.


Table 2. Lesser Common types of Eczema.
Classification Description
Dyshidrosis
(Dyshidrotic Eczema, Pompholyx, Vesicular Palmoplantar Dermatitis, or Housewife’s Eczema)
Nummular Dermatitis
(Discoid Eczema)
Stasis Dermatitis
(Venous Eczema, Gravitational Eczema, Varicose eczema)
Dermatitis herpetiformis
(Duhring’s Disease)
Neurodermatitis
(Localized Scratch Dermatitis, Lichen Simplex Chronicus)
Autoeczematization
(Autosensitization)

Source

“Dyshidrotic eczema – Symptoms and causes | National Eczema Association”.

References

  1. Johansson SG, Hourihane JO, Bousquet J; et al. (2001). “A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force”. Allergy. 56 (9): 813–24. PMID 11551246.
  2. Peters N, Peters AT (2019). “Atopic dermatitis”. Allergy Asthma Proc. 40 (6): 433–436. doi:10.2500/aap.2019.40.4265. PMID 31690388.
  3. Sampogna F, Linder D, Piaserico S, Altomare G, Bortune M, Calzavara-Pinton P; et al. (2014). “Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex”. Acta Derm Venereol. 94 (4): 411–4. doi:10.2340/00015555-1731. PMID 24287710.
Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Overview

The mechanism of disease of eczema involves a complex interplay of abnormalities of skin microbiomes, a dysfunction in the epidermal barrier, and an immune dysregulation. [1] There are two main theories on the existence of atopic dermatitis, also known as atopic eczema – the inside-out hypothesis, and the outside-in hypothesis.

Pathophysiology

Immunological Dysregulation

Genetic Inheritance

Epithelium Barrier Dysfunction

Hypotheses on Development of Eczema

References

  1. 1.0 1.1 Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G; et al. (2016). “The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves”. J Allergy Clin Immunol. 138 (2): 500–508.e24. doi:10.1016/j.jaci.2016.02.020. PMID 27212086.
  2. Paternoster L, Standl M, Waage J, Baurecht H, Hotze M, Strachan DP; et al. (2015). “Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis”. Nat Genet. 47 (12): 1449–1456. doi:10.1038/ng.3424. PMC 4753676. PMID 26482879.
  3. Weidinger S, Willis-Owen SA, Kamatani Y, Baurecht H, Morar N, Liang L; et al. (2013). “A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis”. Hum Mol Genet. 22 (23): 4841–56. doi:10.1093/hmg/ddt317. PMC 3820131. PMID 23886662.
  4. Martin MJ, Estravís M, García-Sánchez A, Dávila I, Isidoro-García M, Sanz C (2020). “Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review”. Genes (Basel). 11 (4). doi:10.3390/genes11040442. PMC 7231115 Check |pmc= value (help). PMID 32325630 Check |pmid= value (help).
  5. Seidenari S, Giusti G (1995). “Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin”. Acta Derm Venereol. 75 (6): 429–33. doi:10.2340/0001555575429433. PMID 8651017.
  6. Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Høgh JK; et al. (2010). “Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema”. Allergy. 65 (7): 911–8. doi:10.1111/j.1398-9995.2010.02326.x. PMID 20132155.
  7. Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C (2019). “Atopic dermatitis: the skin barrier and beyond”. Br J Dermatol. 180 (3): 464–474. doi:10.1111/bjd.16934. PMID 29969827.
  8. Halling-Overgaard AS, Kezic S, Jakasa I, Engebretsen KA, Maibach H, Thyssen JP (2017). “Skin absorption through atopic dermatitis skin: a systematic review”. Br J Dermatol. 177 (1): 84–106. doi:10.1111/bjd.15065. PMID 27639188.
  9. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A; et al. (2007). “Cytokine modulation of atopic dermatitis filaggrin skin expression”. J Allergy Clin Immunol. 120 (1): 150–5. doi:10.1016/j.jaci.2007.04.031. PMC 2669594. PMID 17512043.
  10. Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS; et al. (2018). “Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration”. J Allergy Clin Immunol. 141 (5): 1668–1676.e16. doi:10.1016/j.jaci.2018.01.019. PMID 29421277.
  11. 11.0 11.1 11.2 Silverberg NB, Silverberg JI (2015). “Inside out or outside in: does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?”. Cutis. 96 (6): 359–61. PMID 26761930.
  12. Leung DY, Guttman-Yassky E (2014). “Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches”. J Allergy Clin Immunol. 134 (4): 769–79. doi:10.1016/j.jaci.2014.08.008. PMC 4186710. PMID 25282559.
Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Overview

The etiology of eczema is multifactorial and complex. This involves aberrations in genetic components, adverse effects of certain medications, and some environmental factors.

Etiology of Eczema

Genetic problem

Eczema as an Adverse Drug Reaction


Table 1. List of medications with eczema as its adverse effect.
Medication
Cidofovir
Flurbiprofen
Olaparib
Siltuximab
Sorafenib
Tiagabine

References

  1. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP; et al. (2006). “Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis”. Nat Genet. 38 (4): 441–6. doi:10.1038/ng1767. PMID 16550169.
Differentiating Eczema from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]

Overview

Eczema has various mimics with regards to the clinical presentation, severity, and course of disease. A strong clinical evaluation by the physician based on the presenting signs and symptoms is needed to come up with the correct diagnosis. Differential diagnoses of eczema include infectious disease, inflammatory disease, immunodeficiency problem, or a nutritional deficiency.[1]

Differential Diagnosis

A strong clinical evaluation by the physician based on the presenting signs and symptoms is needed to come up with the correct diagnosis.

  • Table 1 summarizes these medical conditions that can mimic the presentation of eczema, with their corresponding expected time of onset.


Table 1. Differential Diagnosis of Eczema.[1]
Type Medical Condition Manifestations Expected Time of Presentation
Inflammatory Psoriasis Adolescence to adulthood.
Viral Exanthem Infancy.
Contact Dermatitis Infancy.
Neoplastic Cutaneous T-cell Lymphoma Adulthood.
Immunodeficiency Wiskott-Aldrich Syndrome Infancy.
Netherton syndrome Infancy.
Hyper IgE syndrome Infancy.
DOCK8 Infancy.
Nutritional Deficiency Zinc Infancy to early childhood.
Biotin Infancy to early childhood.

References

  1. 1.0 1.1 Raveendran R (2019). “Tips and Tricks for Controlling Eczema”. Immunol Allergy Clin North Am. 39 (4): 521–533. doi:10.1016/j.iac.2019.07.006. PMID 31563186.
Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. [1] [2] Eczema has more predilection in males. [3]

Eczema Epidemiology and Demographics

References

  1. 1.0 1.1 Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011). “Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health”. J Invest Dermatol. 131 (1): 67–73. doi:10.1038/jid.2010.251. PMC 3130508. PMID 20739951.
  2. 2.0 2.1 Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC (2015). “Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study”. J Invest Dermatol. 135 (1): 56–66. doi:10.1038/jid.2014.325. PMID 25078665.
  3. 3.0 3.1 Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). “A population-based survey of eczema prevalence in the United States”. Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.
  4. Kim JP, Chao LX, Simpson EL, Silverberg JI (2016). “Persistence of atopic dermatitis (AD): A systematic review and meta-analysis”. J Am Acad Dermatol. 75 (4): 681–687.e11. doi:10.1016/j.jaad.2016.05.028. PMC 5216177. PMID 27544489.
  5. Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS; et al. (2018). “Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration”. J Allergy Clin Immunol. 141 (5): 1668–1676.e16. doi:10.1016/j.jaci.2018.01.019. PMID 29421277.
Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Risk factors of eczema include family history and FLG gene mutation.

Risk Factors

References

  1. Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G; et al. (2016). “The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves”. J Allergy Clin Immunol. 138 (2): 500–508.e24. doi:10.1016/j.jaci.2016.02.020. PMID 27212086.
  2. Sicherer SH, Leung DY (2009). “Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008”. J Allergy Clin Immunol. 123 (2): 319–27. doi:10.1016/j.jaci.2008.12.025. PMID 19203656.
  3. Paternoster L, Standl M, Waage J, Baurecht H, Hotze M, Strachan DP; et al. (2015). “Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis”. Nat Genet. 47 (12): 1449–1456. doi:10.1038/ng.3424. PMC 4753676. PMID 26482879.
  4. Sandilands A, Sutherland C, Irvine AD, McLean WH (2009). “Filaggrin in the frontline: role in skin barrier function and disease”. J Cell Sci. 122 (Pt 9): 1285–94. doi:10.1242/jcs.033969. PMC 2721001. PMID 19386895.
  5. Leung DY, Guttman-Yassky E (2014). “Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches”. J Allergy Clin Immunol. 134 (4): 769–79. doi:10.1016/j.jaci.2014.08.008. PMC 4186710. PMID 25282559.
  6. Irvine AD, McLean WH, Leung DY (2011). “Filaggrin mutations associated with skin and allergic diseases”. N Engl J Med. 365 (14): 1315–27. doi:10.1056/NEJMra1011040. PMID 21991953.
  7. Silverberg JI, Hanifin J, Simpson EL (2013). “Climatic factors are associated with childhood eczema prevalence in the United States”. J Invest Dermatol. 133 (7): 1752–9. doi:10.1038/jid.2013.19. PMC 3646081. PMID 23334343.
Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Hanifin and Rajka criteria are the gold standard for diagnosing eczema. [1] [2]

Eczema screening


Table 1. Hanifin and Rajka Criteria “www.med.or.jp” (PDF).
Major Criteria Minor Criteria
Pruritus Xerosis
Typical morphology and distribution, flexural lichenification in adults, facial and extensor eruptions in infants and children Ichthyosis / palmar hyper-linearity, keratosis pilaris
Chronic or chronically relapsing dermatitis Immediate (type 1) skin-test reactivity
Personal or family history of atopy (asthma, allergic rhinitis, atopic dermatitis) Raised serum IgE
Early age of onset
Tendency toward cutaneous infections (especially Staphylococcus aureus and herpes simplex virus), impaired cell-mediated immunity
Tendency toward non-specific hand or foot dermatitis.
Nipple eczema
Cheilitis
Recurrent conjunctivitis
Dennie-Morgan infraorbital fold
Keratoconus
Anterior subcapsular cataracts
Orbital darkening
Facial pallor, facial erythema
Pityriasis alba
Anterior neck folds
Itch when sweating.
Intolerance to wool and lipid solvents.
Perifollicular accentuation
Food intolerance
Course influenced by environmental or emotional factors
White dermographism, delayed blanch.

References

  1. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL; et al. (2014). “Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis”. J Am Acad Dermatol. 70 (2): 338–51. doi:10.1016/j.jaad.2013.10.010. PMC 4410183. PMID 24290431.
  2. Schulte-Herbrüggen O, Fölster-Holst R, von Elstermann M, Augustin M, Hellweg R (2007). “Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis”. Int Arch Allergy Immunol. 144 (3): 211–6. doi:10.1159/000103994. PMID 17579279.
  3. Avena-Woods C (2017). “Overview of atopic dermatitis”. Am J Manag Care. 23 (8 Suppl): S115–S123. PMID 28978208.
Natural History, Complications, and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Eczema has regarded as a medical condition with a natural history that occurs consistently. It is characterized as a disease with an early onset, mostly during the childhood period, and remits during the adolescence period. If eczema is left untreated, it can lead to viral, bacterial and fungal infections. Psychological problems could also arise brought about by constant itching.

Eczema Natural History, Complications, and Prognosis

Natural History

  • Eczema has regarded as a medical condition with a natural history that occurs consistently.
  • It is characterized as a disease with an early onset, mostly during the childhood period, and remits during the adolescence period. [1]

Comorbidities

Complications

Prognosis

References

  1. Paternoster L, Savenije OEM, Heron J, Evans DM, Vonk JM, Brunekreef B; et al. (2018). “Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts”. J Allergy Clin Immunol. 141 (3): 964–971. doi:10.1016/j.jaci.2017.09.044. PMC 5840507. PMID 29129583.
  2. Holgate ST (2007). “The epithelium takes centre stage in asthma and atopic dermatitis”. Trends Immunol. 28 (6): 248–51. doi:10.1016/j.it.2007.04.007. PMID 17466594.
  3. Zheng T, Yu J, Oh MH, Zhu Z (2011). “The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma”. Allergy Asthma Immunol Res. 3 (2): 67–73. doi:10.4168/aair.2011.3.2.67. PMC 3062798. PMID 21461244.
  4. de Groot AC (1990). “The frequency of contact allergy in atopic patients with dermatitis”. Contact Dermatitis. 22 (5): 273–7. doi:10.1111/j.1600-0536.1990.tb01595.x. PMID 2383986.
  5. 5.0 5.1 Jackson PG, Lessof MH, Baker RW, Ferrett J, MacDonald DM (1981). “Intestinal permeability in patients with eczema and food allergy”. Lancet. 1 (8233): 1285–6. doi:10.1016/s0140-6736(81)92459-4. PMID 6112605.
  6. Kulthanan K, Tuchinda P, Nitiyarom R, Chunharas A, Chantaphakul H, Aunhachoke K; et al. (2021). “Clinical practice guidelines for the diagnosis and management of atopic dermatitis”. Asian Pac J Allergy Immunol. 39 (3): 145–155. doi:10.12932/AP-010221-1050. PMID 34246205 Check |pmid= value (help).
  7. Togias A, Cooper SF, Acebal ML, Assa’ad A, Baker JR, Beck LA; et al. (2017). “Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel”. J Pediatr Nurs. 32: 91–98. doi:10.1016/j.pedn.2016.12.006. PMID 28137368.
  8. Silverberg JI, Kleiman E, Lev-Tov H, Silverberg NB, Durkin HG, Joks R; et al. (2011). “Association between obesity and atopic dermatitis in childhood: a case-control study”. J Allergy Clin Immunol. 127 (5): 1180–6.e1. doi:10.1016/j.jaci.2011.01.063. PMID 21411132.
  9. Yaghmaie P, Koudelka CW, Simpson EL (2013). “Mental health comorbidity in patients with atopic dermatitis”. J Allergy Clin Immunol. 131 (2): 428–33. doi:10.1016/j.jaci.2012.10.041. PMC 3565469. PMID 23245818.
  10. Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V (2013). “Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder”. Psychoneuroendocrinology. 38 (1): 12–23. doi:10.1016/j.psyneuen.2012.09.017. PMID 23141851.
  11. Nicholas MN, Gooderham MJ (2017). “Atopic Dermatitis, Depression, and Suicidality”. J Cutan Med Surg. 21 (3): 237–242. doi:10.1177/1203475416685078. PMID 28300443.
  12. Kim JP, Chao LX, Simpson EL, Silverberg JI (2016). “Persistence of atopic dermatitis (AD): A systematic review and meta-analysis”. J Am Acad Dermatol. 75 (4): 681–687.e11. doi:10.1016/j.jaad.2016.05.028. PMC 5216177. PMID 27544489.
  13. Meding B, Wrangsjö K, Järvholm B (2005). “Fifteen-year follow-up of hand eczema: persistence and consequences”. Br J Dermatol. 152 (5): 975–80. doi:10.1111/j.1365-2133.2005.06494.x. PMID 15888155.
  14. Olesen CM, Agner T, Ebbehøj NE, Carøe TK (2019). “Factors influencing prognosis for occupational hand eczema: new trends”. Br J Dermatol. 181 (6): 1280–1286. doi:10.1111/bjd.17870. PMID 30851194.
Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Social Impact | Future or Investigational Therapies
Case Studies

Case Studies

Case #1
External links


ca:Èczema cs:ekzém de:Ekzem eo:Ekzemo io:Ekzemo it:Eczema he:גרב (מחלה) nl:Eczeem sv:Eksem uk:Екзема


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH